Invention Grant
- Patent Title: Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
-
Application No.: US16216420Application Date: 2018-12-11
-
Publication No.: US10550102B2Publication Date: 2020-02-04
- Inventor: Christopher M. Adams , Doug Bevan , Michael Paul Capparelli , Takeru Ehara , Luciana Ferrara , Nan Ji , Erik Meredith , Muneto Mogi , James J. Powers , Ganesh Prasanna , Nello Mainolfi , Mitsunori Kato
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Sophie Binet Cross
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D413/14 ; C07D401/10 ; C07D401/12 ; A61K9/00 ; A61K31/4439 ; A61K31/454 ; A61K31/4545 ; A61K31/4725 ; C07D405/14 ; C07D401/04
Abstract:
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Public/Granted literature
- US20190119254A1 INDANE AND INDOLINE DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS Public/Granted day:2019-04-25
Information query
